SkinStylus Wins FDA Clearance for Periorbital Wrinkles—A New Benchmark in Microneedling Technology
Market Chameleon (Tue, 7-Jul 6:28 AM ET)
SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
Globe Newswire (Tue, 7-Jul 8:05 AM ET)
AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds
PRNewswire (Tue, 23-Jun 1:00 PM ET)
Hydrafacial Introduces HydraScalp with Keravive as Next Evolution in Scalp Health
Globe Newswire (Tue, 2-Jun 8:05 AM ET)
SkinHealth Systems Reports First Quarter 2026 Financial Results
Globe Newswire (Thu, 7-May 4:05 PM ET)
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
Globe Newswire (Wed, 29-Apr 10:00 AM ET)
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
Globe Newswire (Wed, 22-Apr 4:05 PM ET)
Globe Newswire (Wed, 22-Apr 8:00 AM ET)
Market Chameleon (Fri, 13-Mar 7:09 AM ET)
Market Chameleon (Fri, 7-Nov 5:33 AM ET)
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
Skinhealth Systems - Class A trades on the NASDAQ stock market under the symbol SKIN.
As of July 9, 2026, SKIN stock price declined to $0.94 with 3,372,520 million shares trading.
SKIN has a beta of 2.78, meaning it tends to be more sensitive to market movements. SKIN has a correlation of 0.13 to the broad based SPY ETF.
SKIN has a market cap of $122.21 million. This is considered a Micro Cap stock.
Last quarter Skinhealth Systems - Class A reported $65 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.03.
In the last 3 years, SKIN traded as high as $8.96 and as low as $.55.
The top ETF exchange traded funds that SKIN belongs to (by Net Assets): VTI, VXF, VTWO, SCHA, VTWG.
SKIN has underperformed the market in the last year with a return of -55.1%, while the SPY ETF gained +22.4%. In the last 3 month period, SKIN fell short of the market, returning +1.2%, while SPY returned +11.5%. However, in the most recent 2 weeks SKIN has outperformed the stock market by returning +42.9%, while SPY returned +2.5%.
SKIN support price is $.97 and resistance is $1.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SKIN shares will trade within this expected range on the day.